AssayIndex
Reports by quarter

Reports submitted in 2024-Q1 · page 3

Backfill quarter. Reports assayed earlier were accepted retrospectively where custody could be documented. Median purity for the quarter is 99.23 % area, n=161. Read the 2024-Q1 state-of-the-index report →

161 records5 pagesmedian on this page 99.16 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-005207SemaglutideCPCCPC-2309-A1413Janoshik2024-Q197.575.0888.7Buyer-sourced1MARGINAL
AX-2024-004288TB-500QSCQSC-2401-S6494Janoshik2024-Q199.916.42—Buyer-sourced1MARGINAL
AX-2024-004153DesmopressinWWBWWB-2312-E2908Janoshik2024-Q199.545.52101.8Buyer-sourced0PASS
AX-2024-005184SemaxCPCCPC-2309-M9933Janoshik2024-Q198.516.16—Supplier-supplied0PASS
AX-2024-004452HexarelinGSPGSP-2311-C2917Janoshik2024-Q198.793.84107.4Buyer-sourced0FAIL
AX-2024-004132SemaxWWBWWB-2308-N1754Janoshik2024-Q199.515.1194.6Laboratory-retained0PASS
AX-2024-005339EpitalonSIGSIG-2308-5947PeptideMeter2024-Q198.859.25—Buyer-sourced0FAIL
AX-2024-004204IGF-1 LR3WWBWWB-2310-A4053Janoshik2024-Q198.734.69107.0Buyer-sourced0PASS
AX-2024-004656RetatrutideTFCTFC-2309-H2397Janoshik2024-Q198.494.83—Buyer-sourced1FAIL
AX-2024-004651RetatrutideTFCTFC-2309-H2397Janoshik2024-Q198.863.9099.4Buyer-sourced0PASS
AX-2024-004572SemaglutideJEEPJEEP-2308-J8740Kestrel2024-Q199.936.0795.2Laboratory-retained0PASS
AX-2024-005315AfamelanotideBCHBCH-2310-K5538Janoshik2024-Q198.105.68—Buyer-sourced0PASS
AX-2024-005176SemaxCPCCPC-2309-M9933Kestrel2024-Q198.475.9792.7Buyer-sourced0FAIL
AX-2024-004737TB-500HomopeptideHOMO-2308-R3867PeptideMeter2024-Q199.493.86101.5Buyer-sourced0PASS
AX-2024-004129SemaxWWBWWB-2308-N1754Janoshik2024-Q199.665.44—Buyer-sourced0PASS
AX-2024-004612PT-141 (Bremelanotide)TFCTFC-2310-J1196Janoshik2024-Q199.937.65103.0Buyer-sourced0PASS
AX-2024-004455BPC-157GSPGSP-2402-G3728VendorInvestigate2024-Q198.933.6990.4Buyer-sourced1MARGINAL
AX-2024-004315Melanotan IIQSCQSC-2402-L6963Janoshik2024-Q199.405.33—Buyer-sourced0PASS
AX-2024-005316AfamelanotideBCHBCH-2310-K5538PeptideMeter2024-Q197.575.14—Buyer-sourced1FAIL
AX-2024-004286TB-500QSCQSC-2401-S6494PeptideMeter2024-Q199.836.17101.9Buyer-sourced1MARGINAL
AX-2024-004661RetatrutideTFCTFC-2309-H2397VendorInvestigate2024-Q198.504.3496.3Buyer-sourced0PASS
AX-2024-004617PT-141 (Bremelanotide)TFCTFC-2310-J1196Nordanalyt2024-Q199.938.62100.9Buyer-sourced0FAIL
AX-2024-004203IGF-1 LR3WWBWWB-2310-A4053Medutest2024-Q199.124.78—Buyer-sourced0PASS
AX-2024-004657RetatrutideTFCTFC-2309-H2397PeptideMeter2024-Q198.674.27—Buyer-sourced0PASS
AX-2024-004646RetatrutideTFCTFC-2309-H2397Nordanalyt2024-Q198.674.32102.6Buyer-sourced2FAIL
AX-2024-004611PT-141 (Bremelanotide)TFCTFC-2310-J1196Janoshik2024-Q199.937.8690.5Buyer-sourced0PASS
AX-2024-004126SemaxWWBWWB-2308-N1754Janoshik2024-Q199.525.2895.9Buyer-sourced0PASS
AX-2024-004121SemaxWWBWWB-2308-N1754VendorInvestigate2024-Q199.274.9296.0Buyer-sourced0PASS
AX-2024-004476TirzepatideAMBAMB-2309-P5844VendorInvestigate2024-Q198.414.49102.2Buyer-sourced0PASS
AX-2024-004384RetatrutideTFSTFS-{CAT}-9522Janoshik2024-Q198.494.4099.4Buyer-sourced0PASS
AX-2024-004202IGF-1 LR3WWBWWB-2310-A4053Janoshik2024-Q199.215.9597.0Buyer-sourced0PASS
AX-2024-004647RetatrutideTFCTFC-2309-H2397Nordanalyt2024-Q198.504.42—Supplier-supplied0PASS
AX-2024-004450HexarelinGSPGSP-2311-C2917Janoshik2024-Q199.025.03—Buyer-sourced0PASS
AX-2024-004380RetatrutideTFSTFS-{CAT}-9522Nordanalyt2024-Q198.774.04—Buyer-sourced0PASS
AX-2024-004124SemaxWWBWWB-2308-N1754Nordanalyt2024-Q199.685.32104.7Buyer-sourced0PASS
AX-2024-004743TB-500HomopeptideHOMO-2308-R3867Janoshik2024-Q199.703.4088.9Buyer-sourced1MARGINAL
AX-2024-004610PT-141 (Bremelanotide)TFCTFC-2310-J1196Janoshik2024-Q199.747.3796.4Buyer-sourced0PASS
AX-2024-004323Melanotan IIQSCQSC-2402-L6963Nordanalyt2024-Q199.596.21—Buyer-sourced0PASS
AX-2024-004275PT-141 (Bremelanotide)QSCQSC-2402-X6189Janoshik2024-Q199.393.4799.6Buyer-sourced0PASS
AX-2024-004285TB-500QSCQSC-2401-S6494Medutest2024-Q199.936.53107.0Buyer-sourced2FAIL